Andrew Gordon, MD
Vascular & Interventional Radiology · Chicago, ILNPI 1578911061
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,500 of the $8,857 with a category attached, or 62.1%. Amgen accounts for 62.1% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $5,854, 2.6 times the $2,235 reported in 2020.
Across 27 payments — averaging $328.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$6K
- AstraZeneca$2K
- Boston Scientific$643
- Penumbra, Inc.$285
- ABK Biomedical USA, Inc.$222
- W. L. Gore & Associates, Inc.$39
- plus $69 from 3 others
Across 6 payments — averaging $4302.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$26K
What the payments were for
- Consulting fees$5,50062%
- Speaking & faculty fees$2,10024%
- Food & beverage$1,25714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $5,500 |
| AstraZeneca | 1 | $2,100 |
| Boston Scientific | 12 | $643 |
| Penumbra, Inc. | 4 | $285 |
| ABK Biomedical USA, Inc. | 2 | $222 |
| W. L. Gore & Associates, Inc. | 2 | $39 |
| Terumo Medical Corporation | 2 | $37 |
| Argon Medical Devices, Inc. | 1 | $19 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$5,500
- SOLIRIS$2,100
- Eye90 microspheres$222
- RUBY Coil$146
- GENERAL - THERAPIES$135
How this compares
$8,857 in reported general payments places this provider in the 75th percentile of 197 vascular & interventional radiology providers in Illinois.
See all vascular & interventional radiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in Chicago
- Riad SalemChicago$2.3M
- Kush DesaiChicago$1M
- Robert LewandowskiChicago$954K
- Christopher MolvarChicago$850K
- Sreekumar MadasseryChicago$459K
- Bulent ArslanChicago$300K
- Sameer AnsariChicago$161K
- Ahsun RiazChicago$127K
- Ramona GuptaChicago$72K
- Scott ResnickChicago$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.